Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist

Dr. Zengxin Gao | Medicine and Health Sciences | Innovative Research Award

Department of Orthopedics, Zhongda Hospital, Southeast University School of Medicine | China

Dr. Zengxin Gao is a highly accomplished Chief Physician at Southeast University, Affiliated Zhongda Hospital, recognized for his expertise in orthopedics and minimally invasive spinal interventions. He completed his PhD in Orthopedics at Peking Union Medical College in 2008, following a Master’s degree in Orthopedics (2005) and a Bachelor’s degree in Clinical Medicine from Nanjing Medical University (1990). Dr. Zengxin Gao’s clinical career spans over 30 years, beginning as a physician at Nantong University Affiliated Dongtai Hospital, advancing to attending and associate chief physician, and currently serving as Chief Physician at Southeast University Affiliated Zhongda Hospital since 2015. His research focuses on spinal surgery, intervertebral disc regeneration, and innovative minimally invasive techniques for chronic low back and leg pain, particularly in elderly patients. He has led notable projects, including the Jiangsu Provincial Health Commission’s New Technology Introduction Project on percutaneous single-axis hole microscopy (2021–2023). Dr. Zengxin Gao has made significant scholarly contributions, including sole corresponding authorship in Wenbin Xuan, Yucheng Gao, Zengxin Gao. Intraspinal Bone Fragments Resorption in Thoracolumbar Burst Fracture. JAMA Neurol. 2023;80(11):1248–1249 [Cited 12]; co-first authorship in Linhui Ye, Zengxin Gao, Saeed Rohani. Intervertebral disk regeneration in a rat model by allopurinol-loaded Chitosan/alginate hydrogel. Biomol Biomed. 2023;23(4):661–670 [Cited 5]; and co-corresponding authorship in Shuhua Fang et al. Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskelet Disord. 2024;25:5 [Cited 3]. He has been awarded the Provincial and Ministerial First Prize for the Medical New Technology Introduction Award (2022) for pioneering percutaneous transforaminal endoscopic intervertebral fusion. Dr. Zengxin Gao’s combination of clinical expertise, innovative research, and leadership in orthopedics underscores his outstanding contributions and makes him an ideal candidate for the Innovative Research Award.

Profile: Scopus

Featured Publications

• Xuan, W., Gao, Y., & Gao, Z. (2023). Intraspinal bone fragments resorption in thoracolumbar burst fracture. JAMA Neurology, 80(11), 1248–1249.
https://doi.org/10.1001/jamaneurol.2023.2901

• Ye, L., Gao, Z., & Rohani, S. (2023). Intervertebral disk regeneration in a rat model by allopurinol-loaded chitosan/alginate hydrogel. Biomolecules and Biomedicine, 23(4), 661–670.
https://doi.org/10.17305/bjbms.2023.8535

• Fang, S., Cao, D., Wu, Z., Chen, J., Huang, Y., Shen, Y., & Gao, Z. (2024). Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression. BMC Musculoskeletal Disorders, 25(1), 5.
https://doi.org/10.1186/s12891-023-07172-0

• Gao, Z., Lin, Y., Wu, Z., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2020). LncRNA SNHG6 can regulate the proliferation and apoptosis of rat degenerate nucleus pulposus cells via regulating the expression of miR-101-3p. European Review for Medical and Pharmacological Sciences, 24(16), 8251–8262.
https://doi.org/10.26355/eurrev_202008_22592

• Gao, Z., Lin, Y., Zhang, P., Cheng, Q., Ye, L., Wu, F., Chen, Y., Fu, M., Cheng, C., & Gao, Y. (2019). Sinomenine ameliorates intervertebral disc degeneration via inhibition of apoptosis and autophagy in vitro and in vivo. American Journal of Translational Research, 11(9), 5956–5966.
https://www.ajtr.org/files/ajtr0094769.pdf

Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

University Hospital Basel | Switzerland

Dr. Andrej Sirek is a dedicated Pathology Resident at the University Hospital Basel, Institute of Medical Genetics and Pathology, where he is actively shaping his career at the intersection of clinical diagnostics and medical research. With his educational foundation built in leading European institutions, Dr. Andrej Sirek has developed a strong grounding in medical genetics, histopathology, and laboratory sciences, which now supports his dual role as both clinician and researcher. His residency provides him with exposure to complex pathology cases while also allowing him to engage in research that seeks to bridge genetic profiling and diagnostic pathology, with the long-term aim of contributing to precision medicine and early disease detection. Currently, he has completed one research project and is progressing with another, both expected to yield indexed publications in the near future. Despite being at an early stage of his academic career, his commitment to innovation in pathology has already been recognized with a nomination for the Best Researcher Award. He maintains active membership in several professional organizations, including SGPATH, ÖGPATH, SGZ, and ESP, which strengthens his global collaborations and engagement with the wider pathology community. While he has yet to publish peer-reviewed articles, his ongoing research demonstrates his potential to make impactful contributions to the field. His academic and professional journey underscores the promise of a new generation of clinician-scientists who integrate advanced diagnostic techniques with research innovation to improve patient care. Dr. Andrej Sirek’s trajectory highlights his dedication, scholarly potential, and commitment to excellence in pathology and medical genetics.

Profile: ORCID

Featured Publications

Dr. Andrej Sirek has contributed to impactful research in pathology, focusing on diagnostic innovations, tumor biology, and clinicopathological correlations. Key recent publications include:

Sirek, A., Hench, I. B., Hench, J., Alborelli, I., Gross, M. W., Jakscha, J., Schaller, P., Nagel, G., Baumhoer, D., & Tzankov, A. (2025). Recurrent clonal radiotherapy-associated fibroepithelial polyp of the pharynx: Do low grade radiogenic stromal tumours exist? Case report.

Sobottka, B., Vetter, V., Banaei-Esfahani, A., Nowak, M., Lorch, A., Sirek, A., Mertz, K. D., Brunelli, M., Berthold, D., de Leval, L., et al. (2024). Immune phenotype-genotype associations in primary clear cell renal cell carcinoma and matched metastatic tissue.

Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Forensic Scientist

Dr. Meng Ning | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Chiba University | China

Dr. Meng Ning is an accomplished researcher at Chiba University, Japan, recognized for her pioneering work in the epigenetic regulation of cancer. She has made substantial contributions to understanding the non-catalytic roles of chromatin regulators, particularly in gastric cancer. Her expertise bridges molecular biology and clinical gastrointestinal oncology, enabling her to translate laboratory discoveries into potential therapeutic strategies. Meng Ning is known for her meticulous experimental design, innovative application of genome-editing technologies, and dedication to advancing cancer research through both independent studies and collaborative projects.

Professional Profile

ORCID

Education

Dr. Meng Ning completed her doctoral studies at Chiba University, Japan, where she focused on elucidating novel mechanisms of cancer progression. Her Ph.D. research revealed a previously unrecognized non-catalytic function of SETD1A in gastric cancer via the E2F4–TAF6 axis. Employing advanced techniques including transcriptomics, epigenomics, and genome-editing approaches, she was able to demonstrate this mechanism independently of traditional methyltransferase activity. Her academic training combines rigorous laboratory research with a strong foundation in clinical oncology, preparing her to conduct translational studies that link fundamental discoveries with therapeutic potential.

Experience

Dr. Meng Ning has extensive experience in both experimental and translational cancer research. She has collaborated with the Department of Pathology at the University of Tokyo to analyze clinical gastric cancer specimens, integrating molecular findings with patient data. Her work spans NGS-based studies, CRISPR genome editing, and multi-omics analyses, reflecting a versatile approach to cancer biology. Beyond laboratory research, she has contributed to the mentorship of junior researchers, participated in collaborative projects across institutions, and actively engaged in the scientific community through professional society memberships and research networks.

Research Interests

Dr. Meng Ning’s primary research interest lies in the epigenetic regulation of cancer, with a focus on non-catalytic functions of chromatin regulators. She investigates how these regulators influence tumor proliferation, cellular signaling, and transcriptional networks using advanced molecular biology techniques. Her research integrates next-generation sequencing, genome editing, and integrative bioinformatics to identify novel mechanisms underlying cancer progression. By connecting these molecular insights with clinical oncology, she aims to identify potential therapeutic targets and contribute to the development of innovative cancer treatments.

Awards

Dr. Meng Ning is nominated for the Best Researcher Award in recognition of her outstanding contributions to cancer epigenetics and translational oncology. Her research has introduced novel concepts in understanding chromatin regulator function and tumor biology, demonstrating originality, technical excellence, and significant impact in the field. Her dedication to advancing cancer research through rigorous experimentation and collaborative endeavors positions her as a leading researcher in her discipline.

Publications

Dr. Meng Ning has authored several high-impact, SCI-indexed publications as first or contributing author. Her work demonstrates innovative methodologies and deep insights into the molecular mechanisms of cancer:

Title: Non-catalytic role of SETD1A promotes gastric cancer cell proliferation through the E2F4–TAF6 axis in the cell cycle
Journal: Cell Death & Disease
Published on: 2025-08-23

Title: Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
Journal: Breast Cancer Research
Published on: 2025-08-11

Title: Integrated enhancer regulatory network by enhancer–promoter looping in gastric cancer
Journal: NAR Cancer
Published on: 2024-04-08

Conclusion

Dr. Meng Ning exemplifies excellence in scientific research through her innovative studies in cancer epigenetics and her commitment to translational application. Her work bridges basic molecular discoveries and clinical oncology, offering new avenues for therapeutic development. With a combination of technical skill, collaborative engagement, and visionary research, Meng Ning stands out as a highly deserving candidate for the Best Researcher Award. Her contributions not only advance the understanding of cancer biology but also inspire ongoing innovation in epigenetic and translational research.

Yang Li | Biology and Life Sciences | Best Researcher Award

Published on by Forensic Scientist

Mrs. Yang Li | Biology and Life Sciences | Best Researcher Award

The First Affiliated Hospital of Kunming Medical University | China

Mrs. Yang Li is a committed attending doctor at the First Affiliated Hospital of Kunming Medical University, where she integrates clinical service with translational research. With a strong foundation in endocrinology and metabolic diseases, her academic and clinical endeavors focus on diabetic complications, particularly type 2 diabetic nephropathy. Her contributions to both provincial and national-level projects highlight her dedication to improving patient outcomes through evidence-based research.

Professional Profile

Scopus

Education

Mrs. Yang Li began her academic journey in clinical medicine at Tongji Medical College, one of China’s top-tier medical institutions. She specialized in endocrinology and metabolic diseases, laying a strong academic foundation in chronic disease management, hormonal regulation, and metabolic dysfunctions. Her education was marked by excellence in both theoretical understanding and hands-on training in hospital environments. Continuing her commitment to academic advancement, she is currently pursuing an academic master’s degree, with research embedded into her clinical role. Her educational path reflects a lifelong commitment to improving the diagnosis, treatment, and understanding of chronic metabolic disorders such as diabetes and its complications.

Experience

Mrs. Li’s professional experience encompasses extensive clinical practice, medical education, and rigorous scientific research. At the First Affiliated Hospital of Kunming Medical University, she functions both as a frontline clinician and a research investigator. Her clinical work has given her firsthand insight into the complexities of diabetic complications, particularly diabetic nephropathy. This experience fuels her research endeavors, allowing her to design studies that are both clinically relevant and methodologically sound. She has independently led two provincially funded research projects and participated in two nationally funded projects under the National Natural Science Foundation of China. Her dual role has equipped her with the skills to integrate clinical questions into laboratory settings and translate scientific findings back into patient care protocols.

Research Interest

Mrs. Li’s core research interests revolve around type 2 diabetic nephropathy, particularly the molecular mechanisms driving renal damage in diabetic patients. Her work investigates the interplay between metabolic stress, adipose tissue function, vascular endothelial integrity, and renal cellular injury. Of special interest is the role of perirenal adipose tissue in modulating the onset and progression of diabetic kidney disease, a relatively underexplored area that may yield novel diagnostic and therapeutic strategies. She is also interested in transcriptomics, signaling pathways such as TGF-β1, and the protective role of ACE2–Ang-(1-7)–Mas receptor axes in pancreatic and renal tissues. Through her research, she aims to uncover early biomarkers and develop targeted interventions that can prevent or slow the progression of diabetic nephropathy.

Award

Mrs. Yang Li is an exemplary nominee for the Best Researcher Award, a recognition that would honor her persistent and impactful contributions to clinical science. Her ability to lead government-funded projects, publish in respected international journals, and remain active in frontline patient care places her among the most promising early-career physician-researchers in China. The translational nature of her research directly addresses one of the world’s most pressing public health concerns: diabetes and its complications. Her leadership, scientific rigor, and commitment to evidence-based medicine make her a deserving recipient of this prestigious award.

Publications

Mrs. Yang Li has published four peer-reviewed articles in reputable SCI-indexed journals, reflecting her growing influence in the field of diabetic complications. Each of her publications contributes to a deeper understanding of the pathophysiological mechanisms behind diabetes and its impact on vital organs:

Title: Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis via AKT, eNOS, p38 MAPK, and JNK pathways
Journal: Journal of Diabetes Research
Published on: 2014
Citation: Cited by 64 articles

Title: The ACE2–Ang-(1-7)–Mas axis improves microvascular endothelial cell function in pancreatic β cells
Journal: International Journal of Molecular Medicine
Published on: 2014
Citation: Cited by 91 studies

Title: Scutellarin ameliorates diabetic nephropathy via the TGF-β1 signaling pathway
Journal: Natural Products and Bioprospecting
Published on: 2024
Citation: Cited by 6 articles

Title: Transcriptomic analysis of ceRNA regulatory networks in perirenal adipose tissue of T2DM SD rats with diabetic nephropathy
Journal: Biotechnology and Applied Biochemistry
Published on: 2025
Citation: Cited by 2 articles

Conclusion

Mrs. Yang Li exemplifies the integration of clinical excellence and scientific innovation. Her work has advanced the understanding of diabetic nephropathy at both cellular and systemic levels, contributing new insights into its prevention and treatment. By combining patient care with a robust research portfolio, she continues to bridge the gap between laboratory discovery and clinical application. Her academic background, research leadership, and impactful publications collectively highlight her qualifications for prestigious research recognition. With her contributions resonating across endocrinology and nephrology, Mrs. Yang Li stands as a valuable asset to the medical and scientific community.

Angela Fernandes | Agricultural and Biological Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Angela Fernandes | Agricultural and Biological Sciences | Best Researcher Award

Mountain Research Center of the Polytechnic Institute of Bragança | Portugal

Dr. Ângela Sofia Feitor Fernandes is an accomplished Assistant Researcher at the Mountain Research Center (CIMO) of the Polytechnic Institute of Bragança, Portugal. With a deep-rooted focus on bioactive compounds and functional food research, she has gained national and international recognition for her contributions to food science and sustainable biotechnologies. Through her multidisciplinary work and international collaborations, Dr. Fernandes has consistently delivered impactful innovations, blending rigorous science with real-world applications.

Author Profile👤

ORCID

Scopus

Strengths for the Awards✨

Dr. Ângela Sofia Feitor Fernandes is a highly accomplished Assistant Researcher at the Mountain Research Center (CIMO-IPB), Portugal. With over 150 peer-reviewed journal publications, an h-index of 39, and editorial contributions across multiple MDPI journals, she has demonstrated exceptional productivity, influence, and scientific leadership in her field. Her expertise spans natural product chemistry, functional food development, and innovative preservation technologies such as gamma irradiation and electron beam techniques.

She has significantly contributed to applied research through projects like VIIAFOOD, TextBlueStyle, and SambucuSafe, translating scientific discoveries into practical innovations for food safety, sustainability, and consumer health. Her work also integrates bioeconomy principles by valorizing agricultural residues into high-value functional foods, showcasing an interdisciplinary and impact-driven approach. Furthermore, her editorial roles, international collaborations, student mentorship, and authorship of seven ISBN-recognized book chapters further validate her academic leadership and global engagement.

🎓 Education

Dr. Fernandes embarked on her academic journey with a degree in Clinical Analysis and Public Health in 2007. She then pursued her Master’s in Food Quality and Safety (2010), followed by a PhD in Pharmaceutical Sciences, specializing in Nutrition and Food Chemistry in 2016. Her studies laid a strong foundation for her later work in food preservation and natural bioactive extraction.

👩‍🔬 Experience

Since 2009, Dr. Fernandes has been an active member of CIMO-IPB, advancing from a researcher to Assistant Researcher. She is currently a key contributor to several high-impact projects, including the VIIAFOOD, TextBlueStyle, and SambucuSafe initiatives. Notably, she pioneered the use of gamma and electron beam irradiation in food technology in Portugal, demonstrating leadership in innovation and sustainable food preservation.

🔬 Research Interests On Agricultural and Biological Sciences

Her research focuses on three primary areas:

  1. Natural Product Chemistry – Extracting, identifying, and isolating bioactive compounds from natural matrices like mushrooms and plants using advanced spectrometric methods.

  2. Functional Foods & Nutraceuticals – Developing bioactive-rich food products with antioxidant, antimicrobial, and cytotoxic properties.

  3. Natural Product Technology – Exploring non-thermal preservation methods such as gamma irradiation to maintain the integrity and shelf life of food, aligning with circular bioeconomy goals.

🏆 Awards & Recognitions

While specific awards are not listed, Dr. Fernandes’ esteemed positions, collaborative international research, editorial leadership for MDPI journals, and participation in prominent European scientific projects stand as strong markers of her academic and scientific excellence. Her rising h-index of 39 and over 150 Scopus-indexed publications validate her distinguished contributions.

📚 Selected Publications

Here are notable peer-reviewed publications by Dr. Fernandes, showcasing her impactful work:

  1. Fernandes, Â. S. F., et al. (2021). Development of functional mushroom flour enriched in vitamin D2. LWT – Food Science and Technology, 145. Cited by 23 articles.

  2. Fernandes, Â. S. F., et al. (2020). Irradiation of wild edible mushrooms: Evaluation of quality and safety parameters. Food Chemistry, 330. Cited by 31 articles.

  3. Fernandes, Â. S. F., et al. (2019). Bioactive potential of elderberry extracts in functional food formulations. Journal of Functional Foods, 59. Cited by 19 articles.

  4. Fernandes, Â. S. F., et al. (2018). Chemical profiling of mushrooms for nutraceutical use. Journal of Chromatography B, 1092. Cited by 27 articles.

  5. Fernandes, Â. S. F., et al. (2022). Natural blue dyes from food waste for textile application. Dyes and Pigments, 199. Cited by 12 articles.

Each publication reflects her expertise in translating scientific discovery into applied solutions.

✅ Conclusion

Dr. Ângela Fernandes is an exemplary candidate for the Best Researcher Award under the Forensic Scientist Awards. Her pioneering efforts in food chemistry, sustainable technologies, and functional food development place her at the forefront of applied biochemistry. Her dedication to a circular economy and bio-based innovation has brought real benefits to industry and academia alike. With a strong scientific record, leadership in international collaborations, and a forward-thinking approach, Dr. Fernandes stands as a model of excellence in research.

Fusheng Liu | Biology | Best Researcher Award

Published on by Forensic Scientist

Dr. Fusheng Liu | Biology | Best Researcher Award

Assistant professor | Xi’an Jiaotong University | China

🌟 Dr. Fusheng Liu is an Assistant Professor at Xi’an Jiaotong University, China. With a rich academic background spanning over a decade, his expertise lies in biomechanics, particularly in the theory and numerical computation of multi-physical field coupling and the mechanical behavior of composite materials. His groundbreaking research has significantly contributed to understanding myocardial fibrosis and pain sensation mechanics.

Profile

Scopus

Orcid

Strengths for the Awards

1️⃣ Academic Excellence:
Dr. Liu holds a robust academic foundation with a PhD, MA, and BA from Xi’an Jiaotong University, where his studies focused on advanced mechanics, solid mechanics, and structural analysis. His doctoral research, titled “Theoretical Investigation into the Coupling Behaviour of Mechanoelectrical Tissue in Myocardial Fibrosis”, has paved the way for deeper insights into cardiac tissue dynamics.

2️⃣ Research Contributions:

  • Published seven high-quality journal articles in esteemed publications such as the International Journal of Molecular Sciences, Biophysical Journal, and Scientific Reports. These works reflect his expertise in modeling biomechanical processes and cellular interactions.
  • His research on fibroblast-cardiomyocyte interactions and myocardial fibrosis provides critical insights for medical science and targeted therapies.

3️⃣ Industry Collaboration and Innovation:
Dr. Liu successfully partnered with Siemens to develop a market-ready facial beauty device, showcasing his ability to translate theoretical knowledge into practical applications.

4️⃣ Recognition and Citations:
With 125 citations on ResearchGate, his work has demonstrated tangible academic impact and recognition within the research community.

5️⃣ Research Focus:
Dr. Liu’s exploration of multi-physical field coupling, mechanical behavior of composite materials, and experimental mechanics places him at the forefront of innovative research in biomechanics.

Education

🎓 Educational Journey

  • PhD in Mechanics (2015-2022), Xi’an Jiaotong University
    Thesis: “Theoretical Investigation into the Coupling Behaviour of Mechanoelectrical Tissue in Myocardial Fibrosis”
  • MA in Solid Mechanics (2013-2015), Xi’an Jiaotong University
  • BA in Structural Analysis of Engineering Structures (2009-2013), Xi’an Jiaotong University

Experience

💼 Professional Background

  • 2023–Present: Assistant Researcher, Xi’an Jiaotong University, China
  • 2022–2023: Assistant Researcher, China Aerodynamics Research and Development Centre
  • Collaboration with Siemens: Developed a facial beauty device integrating biomechanics with engineering, enabling product optimization.
  • Active participant in global cardiovascular disease research projects, presenting findings at international conferences.

Research Interests On Biology

🔬 Core Areas

  • Mechanics of Multi-Physical Field Coupling (Mechanics, Heat Transfer, Electric Fields)
  • Mechanical Behavior of Composite Materials
  • Quantitative Analysis and Experimental Mechanics Measurements

His research emphasizes myocardial fibrosis, mechanoelectrical coupling, and the interplay between matrix structures and electrokinetic functions.

Awards

🏆 Award Nomination

Dr. Liu is nominated for the Best Researcher Award for his innovative work in myocardial fibrosis and biomechanics, providing valuable insights for pathological understanding and targeted treatments.

Publications

📚 Key Research Contributions

  1. “Modeling Fibroblast–Cardiomyocyte Interactions: Unveiling the Role of Ion Currents in Action Potential Modulation”
    • Authors: Dong, Y., Liu, F.
    • Year: 2024
    • Citations: 0
  2. “A new model of myofibroblast-cardiomyocyte interactions and their differences across species”
    • Authors: Liu, F., Wu, H., Yang, X., Lu, T.J., Xu, F.
    • Year: 2021
    • Citations: 3
  3. “Translation of a coated rigid spherical inclusion in an elastic matrix: Exact solution, and implications for mechanobiology”
    • Authors: Chen, X., Li, M., Liu, S., Xu, F., Lu, T.J.
    • Year: 2019
    • Citations: 6
  4. “Engineering mechanical-electrical cell microenvironment in myocardium using advanced biomaterials” (in Chinese)
    • Authors: Xu, F., Zhang, X., Bao, X., Li, Y., Lu, T.
    • Year: 2018
    • Citations: 1
  5. “The race to the nociceptor: mechanical versus temperature effects in thermal pain of dental neurons”
    • Authors: Lin, M., Liu, F., Liu, S., Lu, T.J., Xu, F.
    • Year: 2017
    • Citations: 3
  6. “Paracrine effects of adipose-derived stem cells on matrix stiffness-induced cardiac myofibroblast differentiation via angiotensin II type 1 receptor and smad7”
    • Authors: Yong, K.W., Li, Y., Liu, F., Xu, F., Huang, G.
    • Year: 2016
    • Citations: 53
  7. “Effect of viscoelasticity on skin pain sensation”
    • Authors: Liu, F., Li, C., Liu, S., Lu, T., Xu, F.
    • Year: 2015
    • Citations: 11

Conclusion

✨ Vision and Impact
Dr. Fusheng Liu continues to push the boundaries of biomechanics with his innovative research and collaborative efforts. His dedication to advancing the understanding of myocardial fibrosis and tissue mechanics positions him as a leader in his field, inspiring future researchers and clinicians alike.

Yiyao Cao | Biology | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Yiyao Cao | Biology | Best Researcher Award

Prof. Dr | Zhejiang Provincial Center for Disease Control and Prevention | China

Prof. Dr. Yiyao Cao is a distinguished expert in radiation detection and dose assessment, serving at the Zhejiang Provincial Center for Disease Control and Prevention. With a Doctor of Medicine (M.D.) degree and extensive expertise in radiation protection, Dr. Cao is a dedicated researcher addressing public concerns related to nuclear safety and environmental health. Her contributions have significantly advanced our understanding of the health implications of nuclear power operations.

Profile

Scopus

Strengths for the Awards

  • Specialized Research Focus: Dr. Cao’s expertise in radiation detection and dose assessment, coupled with her significant contribution to assessing radioactivity levels (Tritium and Carbon-14), demonstrates a niche and impactful research domain.
  • Research Output:
    • Published impactful research: The study on Tritium and Carbon-14 around San’ao Nuclear Power Plant highlights public health relevance.
    • Indexed Journals: Contributions to SCI-indexed journals signify the quality of her publications.
  • Innovative and Public Health Relevance:
    • The research addresses public concerns regarding nuclear power plant emissions, showcasing practical applications of findings.
    • Demonstrates a commitment to safeguarding community health through scientific evaluation.
  • Educational and Professional Credentials:
    • Holding an M.D. and leading research projects at the Zhejiang Provincial Center for Disease Control and Prevention indicate her academic and professional caliber.

Education 🎓

Dr. Cao earned her Doctor of Medicine (M.D.) degree, specializing in radiation detection and dose assessment. Her rigorous academic background has laid a strong foundation for her impactful research and innovations in radiation protection and nuclear safety.

Experience 🏢

Prof. Dr. Cao has accumulated years of professional expertise in radiation detection and public health. She has conducted critical studies to evaluate tritium and carbon-14 levels in food near nuclear power plants, ensuring environmental safety. Her leadership at the Zhejiang Provincial CDC reflects her commitment to advancing public health through research and practical applications.

Research Interests On Biology🔬

Dr. Cao focuses on radiation detection and dose assessment, with a special interest in environmental safety related to nuclear power operations. Her work assesses the risks posed by tritium and carbon-14, addressing public health concerns and guiding regulatory standards.

Awards 🏆

Award Nomination: Best Researcher Award
Dr. Cao has been nominated for her groundbreaking contributions to radiation protection research. Her studies have influenced health risk assessments and safety protocols in nuclear power operations.

Publications 📚

  • Efficient separation of Th(IV) from highly acidic solution by microporous resin materials containing two novel phenanthroline phosphonates
    Authors: Xu, L., Zou, Y., Dai, G., Pu, N., Zou, H.
    Year: 2025
    Citations: 0
  • Radon concentration and related employees’ chromosome aberration and micronuclei in subways in a city of Zhejiang Province
    Authors: Xuan, Z., Huang, X., Lai, Z., Zhang, D., Nie, J.
    Year: 2024
    Citations: 0
  • Development and application of UPLC-Q-Orbitrap HRMS methods for the determination of eight metabolites of p-chloronitrobenzene in human urine
    Authors: Wang, P., Xu, Q., Zou, H., Wang, J., Cao, Y.
    Year: 2024
    Citations: 0
  • Determination and human health risk assessment of TFWT, OBT and carbon-14 in seafood around Qinshan Nuclear Power Plant
    Authors: Ma, X., Cao, Y., Zheng, T., Ren, H.
    Year: 2024
    Citations: 1
  • Manganese dioxide decorated kiwi peel powder for efficient removal of lead from aqueous solutions, blood and Traditional Chinese Medicine extracts
    Authors: Gong, H., Cao, Y., Zeng, W., Kai, G., Qian, J.
    Year: 2024
    Citations: 0
  • Achievements in Preparation of Cyclodextrin–Based Porous Materials for Removal of Pollutants
    Authors: Bao, K., Zhang, A., Cao, Y., Xu, L.
    Year: 2024
    Citations: 1
  • Recent progresses in analytical method development for 210Pb in environmental and biological samples
    Authors: Ren, H., Gong, X., Zhou, L., Wang, P., Cao, Y.
    Year: 2024
    Citations: 0
  • Determination of carbon-14 in marine biota using oxidation combustion and gel suspension liquid scintillation counting
    Authors: Cao, Y., Qian, Y., Ren, H., Xie, Y., Ji, Y.
    Year: 2024
    Citations: 2
  • Establishment of OBT/TFWT dataset in seafood in Zhejiang province, China
    Authors: Gong, X., Huang, W., Cao, Y., Wang, P., Ren, H.
    Year: 2024
    Citations: 0
  • Model prediction of radioactivity levels in the environment and food around the world’s first AP 1000 nuclear power unit
    Authors: Wang, P., Huang, W., Zou, H., Xuan, Z., Cao, Y.
    Year: 2024
    Citations: 0

Conclusion ✅

Prof. Dr. Yiyao Cao’s work exemplifies dedication to public health and environmental safety. Through her expertise in radiation detection and dose assessment, she contributes to the well-being of communities and sets high standards in research and practice. Her achievements underscore her suitability for the Best Researcher Award.